AIPYMNTS6 days ago
AI Vaccine Clears Human Trials, Handing Pharma a New Playbook
4 min read
An AI-designed vaccine from the University of Cambridge and DIOSynVax cleared its first human safety trial. The AI analyzed global virus surveillance data, identified patterns across thousands of variants, and engineered a vaccine component no human specified. The result came in under three years, offering pharma a faster, cheaper development model.
Level
Hype check
Tap to vote and see what everyone thinks.
